349 related articles for article (PubMed ID: 25351779)
1. An easy test but a hard decision: ethical issues concerning non-invasive prenatal testing for autosomal recessive disorders.
Skirton H; Goldsmith L; Chitty LS
Eur J Hum Genet; 2015 Aug; 23(8):1004-9. PubMed ID: 25351779
[TBL] [Abstract][Full Text] [Related]
2. Impact of fetal or child loss on parents' perceptions of non-invasive prenatal diagnosis for autosomal recessive conditions.
Pisnoli L; O'Connor A; Goldsmith L; Jackson L; Skirton H
Midwifery; 2016 Mar; 34():105-110. PubMed ID: 26821974
[TBL] [Abstract][Full Text] [Related]
3. Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis.
Hill M; Compton C; Karunaratna M; Lewis C; Chitty L
J Genet Couns; 2014 Dec; 23(6):1012-21. PubMed ID: 24788196
[TBL] [Abstract][Full Text] [Related]
4. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
5. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
[TBL] [Abstract][Full Text] [Related]
6. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
Kai J; Ulph F; Cullinan T; Qureshi N
Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways.
Verhoef TI; Hill M; Drury S; Mason S; Jenkins L; Morris S; Chitty LS
Prenat Diagn; 2016 Jul; 36(7):636-42. PubMed ID: 27107169
[TBL] [Abstract][Full Text] [Related]
8. Cervical trophoblasts for non-invasive single-cell genotyping and prenatal diagnosis.
Pfeifer I; Benachi A; Saker A; Bonnefont JP; Mouawia H; Broncy L; Frydman R; Brival ML; Lacour B; Dachez R; Paterlini-Bréchot P
Placenta; 2016 Jan; 37():56-60. PubMed ID: 26680636
[TBL] [Abstract][Full Text] [Related]
9. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
10. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial.
Dormandy E; Bryan S; Gulliford MC; Roberts TE; Ades AE; Calnan M; Atkin K; Karnon J; Barton PM; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Davis V; Brown K; Juarez-Garcia A; Tsianakas V; Marteau TM
Health Technol Assess; 2010 Apr; 14(20):1-160. PubMed ID: 20416236
[TBL] [Abstract][Full Text] [Related]
11. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications.
Hall A; Bostanci A; Wright CF
Public Health Genomics; 2010; 13(4):246-55. PubMed ID: 20395693
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial.
Dormandy E; Gulliford M; Bryan S; Roberts TE; Calnan M; Atkin K; Karnon J; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Tsianakas V; Jones P; Marteau TM
BMJ; 2010 Oct; 341():c5132. PubMed ID: 20923841
[TBL] [Abstract][Full Text] [Related]
14. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prenatal diagnosis experience in the Çukurova Region of Southern Turkey: detecting paternal mutations of sickle cell anemia and β-thalassemia in cell-free fetal DNA using high-resolution melting analysis.
Yenilmez ED; Tuli A; Evrüke IC
Prenat Diagn; 2013 Nov; 33(11):1054-62. PubMed ID: 23836351
[TBL] [Abstract][Full Text] [Related]
16. Carrier testing for autosomal-recessive disorders.
Vallance H; Ford J
Crit Rev Clin Lab Sci; 2003 Aug; 40(4):473-97. PubMed ID: 14582604
[TBL] [Abstract][Full Text] [Related]
17. Prenatal screening: current practice, new developments, ethical challenges.
de Jong A; Maya I; van Lith JM
Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.
Bruni T; Mameli M; Pravettoni G; Boniolo G
Med Health Care Philos; 2012 Aug; 15(3):321-8. PubMed ID: 21863402
[TBL] [Abstract][Full Text] [Related]
19. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.
Mouawia H; Saker A; Jais JP; Benachi A; Bussières L; Lacour B; Bonnefont JP; Frydman R; Simpson JL; Paterlini-Brechot P
Reprod Biomed Online; 2012 Nov; 25(5):508-20. PubMed ID: 23000084
[TBL] [Abstract][Full Text] [Related]
20. Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening.
Ulph F; Cullinan T; Qureshi N; Kai J
Eur J Hum Genet; 2015 Apr; 23(4):459-65. PubMed ID: 25005733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
